✦ LIBER ✦

Dietary restriction does not prevent nigrostriatal degeneration in the 6-hydroxydopamine model of Parkinson's disease

✍ Scribed by M.T. Armentero; G. Levandis; P. Bramanti; G. Nappi; F. Blandini

Book ID: 116459343
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 231 KB
Volume: 212
Category: Article
ISSN: 0014-4886
DOI: 10.1016/j.expneurol.2008.04.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acupuncture prevents 6-hydroxydopamine-i

Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson’s disease model

✍ H.i-Joon Park; Sabina Lim; Wan-Seok Joo; Chang-Shik Yin; Hyang-Sook Lee; Hye-Jun 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 224 KB

Progressive degeneration of dopamine neu

Progressive degeneration of dopamine neurons in 6-hydroxydopamine rat model of parkinson's disease does not involve activation of caspase-9 and caspase-3

✍ Allison D. Ebert; Hoo Jae Hann; Martha C. Bohn 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

## Abstract 6‐Hydroxydopamine (6‐OHDA), a neurotoxin that causes the death of dopamine (DA) neurons, is commonly used to produce experimental models of Parkinson's disease (PD) in rodents. In the rat model of PD first described by Sauer and Oertel, DA neurons progressively die over several weeks fo

Effect of Different Doses of Estrogen on

Effect of Different Doses of Estrogen on the Nigrostriatal Dopaminergic System in Two 6-Hydroxydopamine-Induced Lesion Models of Parkinson’s Disease

✍ Marcela Ferreira Cordellini; Giovana Piazzetta; Karin Cristine Pinto; Ana Márcia 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 262 KB

Loss of cannabinoid CB1 receptor express

Loss of cannabinoid CB1 receptor expression in the 6-hydroxydopamine-induced nigrostriatal terminal lesion model of Parkinson's disease in the rat

✍ Sinéad Walsh; Katarzyna Mnich; Ken Mackie; Adrienne M. Gorman; David P. Finn; Ei 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 575 KB

l-DOPA-Induced Dyskinesia in the Intrast

l-DOPA-Induced Dyskinesia in the Intrastriatal 6-Hydroxydopamine Model of Parkinson's Disease: Relation to Motor and Cellular Parameters of Nigrostriatal Function

✍ Christian Winkler; Deniz Kirik; Anders Björklund; M.Angela Cenci 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 846 KB

Neuroprotective Strategies in Parkinson'

Neuroprotective Strategies in Parkinson's Disease Using the Models of 6-Hydroxydopamine and MPTP

✍ EDNA GRÜNBLATT; SILVIA MANDEL; MOUSSA B.H. YOUDIM 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB